Hyperlipoproteinemia type 3

MONDO:0018473

Hyperlipoproteinemia (HLP) type 3 is a rare combined hyperlipidemia characterized by high levels of cholesterol and triglycerides, transported by intermediate density lipoproteins (IDLs), and a high risk of premature atherosclerosis and cardiovascular disease.

Also known as: Broad-betalipoproteinemia, HLP type 3, dyslipidaemia type 3, dyslipidemia type 3, familial dysbetalipoproteinemia, familial hyperlipoproteinemia type 3, hyperlipidemia type 3, hyperlipoproteinemia type III

5 clinical trials for this condition and its sub-types, 4 tagged with Hyperlipoproteinemia type 3 itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Familial hyperlipidemia (130)

Including sub-types (5) Tagged with Hyperlipoproteinemia type 3 (4)

Trials to join now! 1 Not yet finished but already full! 2 Completed 1

Can flaxseed oil protect the aging brain? new trial targets APOE4 carriers

Disease control Recruiting now

This study tests whether a daily dose of flaxseed oil (alpha-linolenic acid) can slow memory loss and protect brain blood vessels in older adults with mild cognitive impairment and the APOE4 gene, which raises Alzheimer's risk. Twenty participants will take either the oil or a pl…

Phase 2 • Sponsor: Michal Schnaider Beeri, Ph.D. • Aim: Disease control

Last updated Jun 27, 2026 09:02 UTC

Hyperlipoproteinemia type 3

Where it sits in the disease tree

Can flaxseed oil protect the aging brain? new trial targets APOE4 carriers